genXone
Poznan
About genXone
genXone co-creates science and medicine, help businesses grow and improve the quality of life. GenXone's mission is to popularise genetics in everyday life. They believe that with this approach, they can truly change the world. They are convinced that molecular genetics is the key to transforming their lives and businesses. They develop and make available innovative solutions that improve, simplify and save lives. They also teach how to use them, and they open up new possibilities for business with their tools and expertise. They believe in a future where they are all conscious of genetics and evolution as intrinsic parts of their development. At genXone, they apply nanopore sequencing technology (fourth-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. They are the first in Poland commercial certified partner of Oxford Nanopore Technologies (ONT), the world leader in biotechnology innovation (www.nanoporetech.com). They specialise in developing new products and solutions based on the latest technologies of nucleic acid sequencing. Their team includes specialists in the field of microbiome research, polygenic diseases, RNA, genomics, metagenomics, bacteriophage transcriptomics, nutrigenomics, genetics of metabolic diseases, molecular ecology and genetic engineering.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $992.6K
- Funding stage: Seed
- Last round: Seed (Apr 2020)
- Website: genxone.euen
- Phone: 48 888 602 308
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/genxone-197033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.